British antifungal developer F2G Ltd has announced a $70mn financing round to push development of its...
Up To Date
Latest News
Sosei Heptares and AbbVie have inked a multi-target licence option drug discovery agreement in neurology.
Researchers have presented a novel method to promote biofilm formation and thus to increase efficiency of...
InflaRx plans to apply for Emergency Use Authorization from the US FDA in Q3/2022 for vilobelimab, the...
Through a $325m SPAC transaction with Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma...
A nasal antibody cocktail binding to the conserved S2 stalk region of SARS-COV-2 might end the corona...
Share
